|
Market Closed -
Nasdaq Copenhagen
01:20:00 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 40.50 DKK | +2.66% |
|
-7.53% | +11.88% |
| 11/09 | Lundbeck's Asedebart Gets US FDA Orphan Drug Designation for Endogenous Cushing's Syndrome | MT |
| 11/09 | Lundbeck wins US orphan drug status for asedebart in Cushing's syndrome | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LUNDBECK | Pharmaceuticals Wholesale | +2.66% | -7.53% | +11.88% | +12.34% | - | 6.41B |  |  | |
- Stock Market
- Stocks
- HLUN B Stock
- LUN Stock
- Charts Lundbeck
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
